Julia Y. Ljubimova

Publications

• Multilayer Films Assembled from Naturally-derived Materials for Controlled Protein Release
  Biomacromolecules. Jun, 2014  |   Pubmed ID: 24825478
• Near-infrared Imaging of Brain Tumors Using the Tumor Paint BLZ-100 to Achieve Near-complete Resection of Brain Tumors
  Neurosurgical Focus. Feb, 2014  |   Pubmed ID: 24484247
• Nanomedicine Therapeutic Approaches to Overcome Cancer Drug Resistance
  Advanced Drug Delivery Reviews. Nov, 2013  |   Pubmed ID: 24120656
• Toxicity and Efficacy Evaluation of Multiple Targeted Polymalic Acid Conjugates for Triple-negative Breast Cancer Treatment
  Journal of Drug Targeting. Dec, 2013  |   Pubmed ID: 24032759
• Polymalic Acid Nanobioconjugate for Simultaneous Immunostimulation and Inhibition of Tumor Growth in HER2/neu-positive Breast Cancer
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2013  |   Pubmed ID: 23770212
• Gene Expression Changes in Rat Brain After Short and Long Exposures to Particulate Matter in Los Angeles Basin Air: Comparison with Human Brain Tumors
  Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie. Nov, 2013  |   Pubmed ID: 23688656
• Distinct Mechanisms of Membrane Permeation Induced by Two Polymalic Acid Copolymers
  Biomaterials. Jan, 2013  |   Pubmed ID: 23063368
• Biocompatible Nanopolymers: the Next Generation of Breast Cancer Treatment?
  Nanomedicine (London, England). Oct, 2012  |   Pubmed ID: 23148535
• Cellular Delivery of Doxorubicin Via PH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid)
  International Journal of Molecular Sciences. 2012  |   Pubmed ID: 23109877
• Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
  PloS One. 2012  |   Pubmed ID: 22355336
• The Transferrin Receptor and the Targeted Delivery of Therapeutic Agents Against Cancer
  Biochimica Et Biophysica Acta. Mar, 2012  |   Pubmed ID: 21851850
• New Functional Degradable and Bio-compatible Nanoparticles Based on Poly(malic Acid) Derivatives for Site-specific Anti-cancer Drug Delivery
  International Journal of Pharmaceutics. Feb, 2012  |   Pubmed ID: 21550387
• Poly(methyl Malate) Nanoparticles: Formation, Degradation, and Encapsulation of Anticancer Drugs
  Macromolecular Bioscience. Oct, 2011  |   Pubmed ID: 21793213
• The Optimization of Polymalic Acid Peptide Copolymers for Endosomolytic Drug Delivery
  Biomaterials. Aug, 2011  |   Pubmed ID: 21514661
• Polymalic Acid-based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting Both HER2/neu Receptor Synthesis and Activity
  Cancer Research. Feb, 2011  |   Pubmed ID: 21303974
• Nanoplatforms for Constructing New Approaches to Cancer Treatment, Imaging, and Drug Delivery: What Should Be the Policy?
  NeuroImage. Jan, 2011  |   Pubmed ID: 20149882
• Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery
  Journal of Nanotechnology. 2010  |   Pubmed ID: 23024655
• Inhibition of Brain Tumor Growth by Intravenous Poly (β-L-malic Acid) Nanobioconjugate with PH-dependent Drug Release [corrected]
  Proceedings of the National Academy of Sciences of the United States of America. Oct, 2010  |   Pubmed ID: 20921419
• Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models
  PloS One. 2010  |   Pubmed ID: 20419092
• Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic Acid)
  Pharmaceutical Research. Nov, 2010  |   Pubmed ID: 20387095
• Adenovirus-driven Overexpression of Proteinases in Organ-cultured Normal Human Corneas Leads to Diabetic-like Changes
  Brain Research Bulletin. Feb, 2010  |   Pubmed ID: 19828126
• Poly(malic Acid) Nanoconjugates Containing Various Antibodies and Oligonucleotides for Multitargeting Drug Delivery
  Nanomedicine (London, England). Apr, 2008  |   Pubmed ID: 18373429
• Nanoconjugate Based on Polymalic Acid for Tumor Targeting
  Chemico-biological Interactions. Jan, 2008  |   Pubmed ID: 17376417
• Brain Tumor Tandem Targeting Using a Combination of Monoclonal Antibodies Attached to Biopoly(beta-L-malic Acid)
  Journal of Controlled Release : Official Journal of the Controlled Release Society. Oct, 2007  |   Pubmed ID: 17630012
• Inhibition of Laminin-8 in Vivo Using a Novel Poly(malic Acid)-based Carrier Reduces Glioma Angiogenesis
  Angiogenesis. 2006  |   Pubmed ID: 17109197
• Polycefin, a New Prototype of a Multifunctional Nanoconjugate Based on Poly(beta-L-malic Acid) for Drug Delivery
  Bioconjugate Chemistry. Mar-Apr, 2006  |   Pubmed ID: 16536461
• Changes in Laminin Isoforms Associated with Brain Tumor Invasion and Angiogenesis
  Frontiers in Bioscience : a Journal and Virtual Library. 2006  |   Pubmed ID: 16146715
• Proteinase and Growth Factor Alterations Revealed by Gene Microarray Analysis of Human Diabetic Corneas
  Investigative Ophthalmology & Visual Science. Oct, 2005  |   Pubmed ID: 16186340
• Overexpression of Beta1-chain-containing Laminins in Capillary Basement Membranes of Human Breast Cancer and Its Metastases
  Breast Cancer Research : BCR. 2005  |   Pubmed ID: 15987446
• Association Between Laminin-8 and Glial Tumor Grade, Recurrence, and Patient Survival
  Cancer. Aug, 2004  |   Pubmed ID: 15274074
• Antisense Inhibition of Laminin-8 Expression Reduces Invasion of Human Gliomas in Vitro
  Molecular Cancer Therapeutics. Oct, 2003  |   Pubmed ID: 14578463